Sprint Bioscience AB (publ) (STO:SPRINT)
Sweden · Delayed Price · Currency is SEK 3.780
+0.030 (0.80%)
Oct 13, 2026, 11:34 AM CET
Sprint Bioscience AB Market Cap
Sprint Bioscience AB has a market cap or net worth of 398.85 million as of October 12, 2026. It is the 32,097th most valuable company in the world and the 423rd biggest in Sweden. Its market cap has increased by 467.57% in one year.
Market Cap
398.85M
Enterprise Value
305.59M
Revenue
139.36M
Global Rank
Country Rank
#423 Sweden
PE Ratio
5.30
ChartMarket Cap Chart
Since November 7, 2014, Sprint Bioscience AB's market cap has increased from 62.49M to 398.85M, an increase of 538.22%. That is a compound annual growth rate of 16.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 398.85M | 157.14% |
| Dec 30, 2025 | 155.11M | 40.43% |
| Dec 30, 2024 | 110.46M | -8.82% |
| Dec 29, 2023 | 121.14M | 449.78% |
| Dec 30, 2022 | 22.03M | -88.47% |
| Dec 30, 2021 | 191.05M | 17.26% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medivir AB | 939.80M |
| Xspray Pharma AB | 521.58M |
| FluoGuide | 513.37M |
| Cantargia AB | 364.27M |
| Corline Biomedical AB | 354.10M |
| Mendus AB | 351.47M |
| Intervacc AB | 300.94M |
| IRLAB Therapeutics AB | 273.33M |